Abstract:Objective To explore the relations between giant cell tumor (GCT) tissues and their peripheral tissues, and to discuss the oncobiological basis of postoperative recurrence and remote metastasis of benign GCT which may provide information for the selection of GCT surgical therapy. Methods From 1998 to 2005, 12 benign GCT specimen were collected in Xijing Hospital of the Fourth Military Medical University. Oncopathology of the tumor focus and the peripheral tissues were analyzed. Tumor position: 6 cases in distal femur, 3 cases in proximal tibia, 1 case in distal bibia, 1 case in fibular capitulum and 1 case in patella.According to Campanacci's radiological image classification, 2 cases at the fibular capitulum and patella were classified grade Ⅰ, 2 cases grade Ⅱ, and 8 cases grade Ⅲ of which 2 cases were complicated with pathological fractures and tumors in 3 cases had invaded into soft tissues and formed neoplastic masses. Six cases were GCT recurrence. According to Enneking's surgical classification, 5 cases were class Ⅰ A and 7 cases were Ⅰ B. Borderlines among GCT tumors and their peripheral tissues (including cortical bone, cancellous bone, cartilage, soft tissues, peripheral vessels as well as vessels inside the tumor) were observed through light microscope. Results At the borderline between GCT and cortical bone, cortical bone erosion by GCT tissues could be found in 9 cases and cutting cones were formed. Tumor growth as digitationes invaded into normal bone tissues could be found in 2 cases. At the borderline between tumor and cancellous bone, reactive stiffened bone or woven bone could be found in 5 cases. There were 2 cases of skip tumor focuses in normal cancellous bone. To be connected to the cartilage, the borderlines of GCT tissue were well-arranged and the articular cartilage surfaces were in integrity. Tumor tissues had invaded osseous tissue limitation in 7 cases, and tumor tissues could be found between two layers of normal fibrous tissues at the borderline between tumor and soft tissues in 4 cases. The wall of blood vessels thickened, the vascular lumen expanded and the increased proliferation in 9 cases in the soft tissues around the tumor. In one case, GCT cells could be seen in expanded vessels outside the integrated bone shells surrounding the tumor. The wall of the arteriole was a little thicker than that of the veinule, and the wall of the veinule was thinner. Vascular smooth muscle was found invaded by mutil-nucleated cells in 2 cases made the wall of the veinule thinner, incomplete or even discontinued, and the muti-nucleated cells entered into the veinules. Conclusion Closely related to postoperative recurrence and metastasis, the distinctive representation of oncobiological behavior at the peripheral tissues of GCT can provide reference for the choice of surgical methods.

Expressions and Clinical Significance of Factors Related to Giant Cell Tumor of Bone

The expression and significance of Skp2,p27 and E2F-1 in giant cell tumor of bone

Imaging Features, Staging System, and Surgical Management of Giant Cell Lesions of the Temporal Bone.

Factors Affecting the Recurrence of Giant Cell Tumor of Bone after Surgery: A Clinicopathological Study of 80 Cases from a Single Center

Factors related to biologic behavior in giant cell tumor of bone

Expressions of CD133 and Ki-67 in giant cell tumor of bone and their clinical significance

Expressions of HSP70 and p57kip2 in giant cell tumor of bone and their clinical significance

Expression and Clinical Significance of Protein CD133 in Giant Cell Tumor of Bone

Tumor immunohistochemistry and preoperative magnetic resonance imaging features predict local recurrence of giant cell tumor of bone following intralesional curettage.

Study on Expression of Basic Fibroblast Growth Factor and Its Receptor in Giant Cell Tumor of Bone and Its Prognostic Factors

[Analysis of the Factors Affecting the Recurrence of Giant Cell Tumor of Bone].

Expressions of P53, Vascular Endothelial Growth Factor in Giant Cell Tumors of Bone and Their Significance

Expression of Ets-1 and C-Myc in Bone Giant Cell Tumors and Their Clinical Significance

Expression and Significance of Ets-1, C-Myc in Giant Cell Tumor of Bone

Identification Of Differentially Expressed Genes And Their Subpathways In Recurrent Versus Primary Bone Giant Cell Tumors

The Expressions of P53 and C-Myc in Giant Cell Tumors of Bone

Expressions of PTEN and MMP-7、VEGF in Giant Cell Tumor of Bone (GCT)

Study on the oncobiological behavior at the peripheral tissues of bone giant cell tumor

Gene Expression Disparity in Giant Cell Tumor of Bone

Recurrence related factors of giant cell tumor of long bone

Expression of CD147, PCNA, VEGF, MMPs and Their Clinical Significance in the Giant Cell Tumor of Bones.